Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01839682 · ClinicalTrials.gov registry record

Evaluation of Outcomes of DFine StabiliT Kyphoplasty in Vertebral Compression Fractures Due to Osteoporosis

A clinical trial of Osteoporosis and Vertebral Fracture, sponsored by Cedars-Sinai Medical Center.

Completed
Registry status
23
Enrollment target
1
Study location

NCT01839682: Completed study of Osteoporosis and Vertebral Fracture, sponsored by Cedars-Sinai Medical Center.

NCT01839682 is a study of Osteoporosis and Vertebral Fracture that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 23 participants, below the 1,546-participant average among 84 other Osteoporosis trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01839682, a study of Osteoporosis and Vertebral Fracture, has completed, sponsored by Cedars-Sinai Medical Center.

COMPLETED
Registry status
23 participants
Enrollment target
1
Study location

Study Summary

This post-market surveillance research project consists of data collection at specified time points using standard questionnaire instruments to compare pain level, mobility and function pre and post procedure using the D-Fine StabiliT® Vertebral Augmentation System and StabiliT® Bone Cement, an FDA approved product used in the standard treatment of vertebral compression fractures.

Primary Outcome

Pain will be assessed using the Visual Assessment Scale (VAS) at enrollment, and interval changes captured at discharge (or 1 day), 1 week, 1 month and 3 months post procedure. Pre and post procedure pain will be compared.

Study Locations (1)

California

  • Cedars-Sinai Medical Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2009-06
Est. Completion 2011-07
Cedars-Sinai Medical Center

339 total trials

What the finished NCT01839682 record still lists

NCT01839682 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,546-participant average among 84 other Osteoporosis trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Osteoporosis appearing as the primary indexed condition, and to 0 interventions.

NCT01839682 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01839682 about?

NCT01839682 is a clinical study titled "Evaluation of Outcomes of DFine StabiliT Kyphoplasty in Vertebral Compression Fractures Due to Osteoporosis". This post-market surveillance research project consists of data collection at specified time points using standard questionnaire instruments to compare pain level, mobility and function pre and post procedure using the D-Fine StabiliT® Vertebral Augmentation System and StabiliT® Bone Cement, an FDA ...

What is the current status of trial NCT01839682?

This trial is currently completed. The enrollment target is 23 participants. The study started on 2009-06. Estimated completion is 2011-07.

What conditions does trial NCT01839682 study?

This clinical trial studies the following conditions: Osteoporosis, Vertebral Fracture.

Who is sponsoring clinical trial NCT01839682?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01839682 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoporosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01839682's enrollment target sits among peer trials

23 74th of 84 higher than 11 of 84 other Osteoporosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoporosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01839682, the US trial registry maintained by the National Library of Medicine. NCT01839682 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.